Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Altered FDG uptake patterns in pediatric lymphoblastic lymphoma patients receiving induction chemotherapy that includes very high dose corticosteroids.

Sharp SE, Gelfand MJ, Absalon MJ.

Pediatr Radiol. 2012 Mar;42(3):331-6. doi: 10.1007/s00247-011-2228-7. Epub 2011 Sep 1.

PMID:
21881935
2.

Normal patterns of 18F-FDG appendiceal uptake in children.

Reavey HE, Alazraki AL, Simoneaux SF.

Pediatr Radiol. 2014 Apr;44(4):398-402. doi: 10.1007/s00247-013-2835-6. Epub 2013 Nov 28.

PMID:
24287869
4.

The effect of oral contrast on large bowel activity in FDG-PET/CT.

Otsuka H, Graham MM, Kubo A, Nishitani H.

Ann Nucl Med. 2005 Apr;19(2):101-8.

PMID:
15909489
5.

Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.

Kazama T, Swanston N, Podoloff DA, Macapinlac HA.

Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1406-11. Epub 2005 Aug 31.

PMID:
16133379
6.

Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact.

Sidhu P, Lin P, Son H, Rosenfeld D, Lin M.

Br J Radiol. 2014 Dec;87(1044):20140472. doi: 10.1259/bjr.20140472. Epub 2014 Oct 21.

7.

The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.

Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S.

Hematol Oncol. 2011 Jun;29(2):67-74. doi: 10.1002/hon.955. Epub 2010 Jul 15.

PMID:
20635328
8.

Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients.

Gelfand MJ, O'hara SM, Curtwright LA, Maclean JR.

Pediatr Radiol. 2005 Oct;35(10):984-90. Epub 2005 Jun 30. Erratum in: Pediatr Radiol. 2011 Apr;41(4):542.

PMID:
15988582
9.

Comparison of 11C-Methionine and 18F-FDG PET/CT for Staging and Follow-up of Pediatric Lymphoma.

Kaste SC, Snyder SE, Metzger ML, Sandlund JT, Howard SC, Krasin M, Shulkin BL.

J Nucl Med. 2017 Mar;58(3):419-424. doi: 10.2967/jnumed.116.178640. Epub 2016 Sep 8.

PMID:
27609791
10.
11.

Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect.

Cohade C.

Semin Nucl Med. 2010 Jul;40(4):283-93. doi: 10.1053/j.semnuclmed.2010.02.001. Review.

PMID:
20513450
12.

Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).

Bucci M, Aparici CM, Hawkins R, Bacharach S, Schrek C, Cheng S, Tong E, Arora S, Parati E, Wintermark M.

J Neuroimaging. 2014 Mar-Apr;24(2):117-23. doi: 10.1111/j.1552-6569.2012.00740.x. Epub 2012 Aug 28.

PMID:
22928741
13.

The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy.

Kawano T, Suzuki A, Ishida A, Takahashi N, Lee J, Tayama Y, Oka T, Yokota S, Inoue T.

Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):831-6. Epub 2004 Feb 13.

PMID:
14963698
14.

Brown adipose tissue 18F-FDG uptake in pediatric PET/CT imaging.

Hong TS, Shammas A, Charron M, Zukotynski KA, Drubach LA, Lim R.

Pediatr Radiol. 2011 Jun;41(6):759-68. doi: 10.1007/s00247-010-1925-y. Epub 2010 Dec 16.

PMID:
21161205
15.

Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.

Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.

J Nucl Med. 2007 Oct;48(10):1662-9. Epub 2007 Sep 14.

16.

The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer.

Hung GU, Lee KW, Liao PY, Yang LH, Yang KT.

Ann Nucl Med. 2008 Jul;22(6):481-5. doi: 10.1007/s12149-008-0149-9. Epub 2008 Aug 1.

PMID:
18670854
17.

Metabolic Skeletal Superscan on 18F-FDG PET/CT in a Case of Acute Lymphoblastic Leukemia.

Parida GK, Soundararajan R, Passah A, Bal C, Kumar R.

Clin Nucl Med. 2015 Jul;40(7):567-8. doi: 10.1097/RLU.0000000000000785.

PMID:
26018718
18.

Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?

Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.

Radiology. 2007 Jul;244(1):257-62.

PMID:
17581905
19.

Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography.

Casey DL, Wexler LH, Fox JJ, Dharmarajan KV, Schoder H, Price AN, Wolden SL.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1136-42. doi: 10.1016/j.ijrobp.2014.08.005.

PMID:
25539372
20.

18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.

Walter F, Federman N, Apichairuk W, Nelson S, Phelps ME, Allen-Auerbach M, Walter MA, Czernin J.

Pediatr Hematol Oncol. 2011 Oct;28(7):579-87. doi: 10.3109/08880018.2011.602180.

PMID:
21936620

Supplemental Content

Support Center